NanoSense

Menu
Book an Appointment
Menu
Book an Appointment

ViruSense

PUBLIC HEALTH — VIRUSENSE

The next pandemic is not a question of if but when.

Covid-19 cost the world 6.7 million lives and $28 trillion. The lesson was clear — early detection is the only answer. ViruSense delivers real-time virus detection without the wait.
Start a conversation about EnviroSense

THE COST OF UNPREPAREDNESS

Coronavirus:
a lesson in unpreparedness.

The IMF raised concerns that the full cost of the pandemic will exceed $28 trillion through 2024. Governments worldwide were criticised for failing to deliver efficient detection and testing capabilities quickly enough.

6.7m

people died Jan 2020 – Dec 2022 fighting for their last breath

$28Tn

IMF projected cost of the pandemic through 2024

€115bn

potential yearly cost of Long Covid — OECD countries alone

0

real-time virus detection solutions existed at outbreak

FROM AEROTOXIC TO PANDEMIC

Early detection
is the only answer.

The WHO confirmed it: early detection is key to combating the spread of coronavirus. Yet throughout the pandemic, governments had no real-time detection capability.

The same NanoSense team that delivered the world’s first real-time organophosphate detector for aircraft recognised that their NPL-verified technology detects compounds 100 times smaller than viruses. The adaptation for virus detection commenced immediately, in collaboration with the UK’s Rosalind Franklin Institute.

The current hantavirus cluster on a cruise ship which has expanded to several countries and the Ebola outbreak in the DRC show how quickly lethal viruses can move from isolated cases to international concern. With hantavirus already causing deaths, healthcare-worker exposure, and cross-border risk, the message is clear: delayed detection gives outbreaks time to spread. ViruSense delivers real-time viral detection without the wait — helping identify threats earlier, isolate faster, and contain outbreaks before they become global crises.

Real-time detection provides real-time protection. ViruSense doesn't wait for results — it delivers them.

The Gap: No Real-Time Testing

Lateral flow and PCR tests are neither real-time nor scalable. They require samples, processing time, and cannot screen public spaces. ViruSense is the first real-time optical virus sensor.

NPL-Verified Sensitivity

The NanoSense platform already detects molecules 100 times smaller than a virus particle — at the chemical building-block level. Virus adaptation is an extension of proven technology, not a new gamble.

Rosalind Franklin Institute Collaboration

The UK’s Rosalind Franklin Institute agreed to collaborate on the ViruSense Covid virus sensor programme — providing world-class scientific validation and development support.

Another Pandemic Is Coming

Bill Gates (18/2/22): advances in medical technology should help the world do a better job of fighting it, if investments are made NOW. ViruSense is that investment.

VIRUSENSE BY NANOSENSE

Virus detection without the wait.
SARS. Influenza. Covid-19 & variants.

164 g

Weight

33 × 23 cm

Form factor

SARS · Flu · Covid

Viruses

Real-time

Time to result

UK · US · EU · JP

Patents

REAL-TIME DETECTION — REAL-TIME PROTECTION

ViruSense: deploy everywhere people gather.

Tier 1 — Immediate Deployment

Airports · Seaports · Border Control Points

Tier 2 — Scale Deployment

Hospitals · Health Centres · Railway Stations Bus & Tube Stations · Supermarkets Public Entertainment Venues & more

$2.6Bn+ 30% EBITDA

Potential revenue from Tier 1 deployment alone
(airports, seaports & border control globally)

No Wait. No Lab. No Delay.

Unlike PCR or lateral flow, ViruSense returns results in real time — enabling immediate isolation, alert, and response before viral spread occurs.

100× Smaller Than a Virus

NPL-verified technology already detects molecular compounds 100 times smaller than virus particles. Virus detection is a natural extension, not a leap of faith.

The next pandemic is coming. Will you be ready?
Start a conversation about ViruSense: nanosense.com